Close
ACHEMA MIDDLE EAST 2026

High Mortality Due To VEXAS Than What Was Previously Thought

As per a recent study that was published in JAMA, a not so well-known syndrome with high mortality has a much higher prevalence than...

WHO Asks For Supply Chain Alterations To Fight Contamination

The World Health Organization has urged regulators, suppliers, as well as medicine manufacturers to take strict steps against medicines in the supply chain that...

Large DNA Sequences Insertion With New Method A Success

Recent work by researchers at Massachusetts General Hospital (MGH) in the US has improved the accuracy of inserting long DNA fragments into genomes. This method...

Antibiotic Shortage In The EU Has Become A Cause For Worry

The current EU antibiotic shortages are being closely watched, according to the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), which...

FDA Intends To Make The Covid-19 Vaccine Process Simpler

The US FDA intends to simplify the COVID-19 vaccine process to make it look more like what happens in case of flu vaccine.This could...

UK Offering An Ideal Ecosystem For ATMP Clinical Trials

The UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 has been published by Cell and Gene Therapy (CGT). T cells were said to...

Hong Kong On The Way To Become Microbiome Hub For APAC

To host the Microbiome Summit 2023 at the Hong Kong Science Park, the medicine faculty of the Chinese University of Hong Kong, Hong Kong...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...